Editorial: Inflammatory muscle diseases: an update

Jantima Tanboon¹, Merrilee Needham^{2

3

4}, Tahseen Mozaffar^{5

6

7}, Werner Stenzel⁸, Ichizo Nishino^{9

10

11}

Affiliations

¹ Department of Pathology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
² University of Notre Dame Australia, Fremantle, WA, Australia.
³ Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, WA, Australia.
⁴ Department of Neurology, Fiona Stanley Hospital, Murdoch, WA, Australia.
⁵ Department of Neurology, School of Medicine, University of California, Irvine, Irvine, CA, United States.
⁶ Pathology and Laboratory Medicine, School of Medicine, University of California, Irvine, Irvine, CA, United States.
⁷ School of Medicine, The Institute for Immunology, University of California, Irvine, Irvine, CA, United States.
⁸ Department of Neuropathology, Berlin Institute of Health (BIH), Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
⁹ Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Tokyo, Japan.
¹⁰ Department of Genome Medicine Development, Medical Genome Center, National Center of Neurology and Psychiatry (NCNP), Tokyo, Japan.
¹¹ Department of Clinical Genome Analysis, Medical Genome Center, National Center of Neurology and Psychiatry (NCNP), Tokyo, Japan.

PMID: 37614973
PMCID: PMC10442951
DOI: 10.3389/fneur.2023.1259275

Editorial

Editorial: Inflammatory muscle diseases: an update

Jantima Tanboon et al. Front Neurol. 2023.

. 2023 Aug 8:14:1259275.

doi: 10.3389/fneur.2023.1259275. eCollection 2023.

Authors

Jantima Tanboon¹, Merrilee Needham^{2

3

4}, Tahseen Mozaffar^{5

6

7}, Werner Stenzel⁸, Ichizo Nishino^{9

10

11}

Affiliations

¹ Department of Pathology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
² University of Notre Dame Australia, Fremantle, WA, Australia.
³ Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, WA, Australia.
⁴ Department of Neurology, Fiona Stanley Hospital, Murdoch, WA, Australia.
⁵ Department of Neurology, School of Medicine, University of California, Irvine, Irvine, CA, United States.
⁶ Pathology and Laboratory Medicine, School of Medicine, University of California, Irvine, Irvine, CA, United States.
⁷ School of Medicine, The Institute for Immunology, University of California, Irvine, Irvine, CA, United States.
⁸ Department of Neuropathology, Berlin Institute of Health (BIH), Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
⁹ Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Tokyo, Japan.
¹⁰ Department of Genome Medicine Development, Medical Genome Center, National Center of Neurology and Psychiatry (NCNP), Tokyo, Japan.
¹¹ Department of Clinical Genome Analysis, Medical Genome Center, National Center of Neurology and Psychiatry (NCNP), Tokyo, Japan.

PMID: 37614973
PMCID: PMC10442951
DOI: 10.3389/fneur.2023.1259275

No abstract available

Keywords: COVID-19; antisynthetase syndrome; dermatomyositis; imaging; immune checkpoint inhibitor; immune mediated necrotizing myopathy; inclusion body myositis; myositis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

Editorial on the Research Topic Inflammatory muscle diseases: an update

References

1. Tanboon J, Uruha A, Stenzel W, Nishino I. Where are we moving in the classification of idiopathic inflammatory myopathies? Curr Opin Neurol. (2020) 33:590–603. 10.1097/WCO.0000000000000855 - DOI - PubMed
1. Lundberg IE, Fujimoto M, Vencovsky J, Aggarwal R, Holmqvist M, Christopher-Stine L, et al. . Idiopathic inflammatory myopathies. Nat Rev Dis Primers. (2021) 7:86. 10.1038/s41572-021-00321-x - DOI - PubMed
1. Mariampillai K, Granger B, Amelin D, Guiguet M, Hachulla E, Maurier F, et al. . Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies. JAMA Neurol. (2018) 75:1528–37. 10.1001/jamaneurol.2018.2598 - DOI - PMC - PubMed
1. Blume G, Pestronk A, Frank B, Johns DR. Polymyositis with cytochrome oxidase negative muscle fibres. Early quadriceps weakness and poor response to immunosuppressive therapy. Brain. (1997) 120:39–45. 10.1093/brain/120.1.39 - DOI - PubMed
1. Kleefeld F, Uruha A, Schänzer A, Nishimura A, Roos A, Schneider U, et al. . Morphologic and molecular patterns of polymyositis with mitochondrial pathology and inclusion body myositis. Neurology. (2022) 99:e2212–22. 10.1212/WNL.0000000000201103 - DOI - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Editorial: Inflammatory muscle diseases: an update

Affiliations

Editorial: Inflammatory muscle diseases: an update

Authors

Affiliations

Conflict of interest statement

Comment on

References

Publication types

Grants and funding

LinkOut - more resources

Full Text Sources